These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38418618)

  • 1. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in diabetes prevalence, awareness, treatment, and control in French-speaking Switzerland.
    Pauli A; de Mestral C; Marques-Vidal P
    Sci Rep; 2024 Feb; 14(1):4839. PubMed ID: 38418618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study.
    Kaiser A; Vollenweider P; Waeber G; Marques-Vidal P
    Diabet Med; 2012 Feb; 29(2):190-7. PubMed ID: 21883431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey.
    Gerber PA; Spirk D; Brändle M; Thoenes M; Lehmann R; Keller U
    Swiss Med Wkly; 2011; 141():w13218. PubMed ID: 21735364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study.
    de Mestral C; Stringhini S; Guessous I; Jornayvaz FR
    Diabet Med; 2020 Aug; 37(8):1374-1378. PubMed ID: 31814147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
    Spirk D; Lareida J; Scheidegger K; Diem P
    Praxis (Bern 1994); 2009 Mar; 98(6):315-20. PubMed ID: 19291638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.
    Danaei G; Finucane MM; Lu Y; Singh GM; Cowan MJ; Paciorek CJ; Lin JK; Farzadfar F; Khang YH; Stevens GA; Rao M; Ali MK; Riley LM; Robinson CA; Ezzati M;
    Lancet; 2011 Jul; 378(9785):31-40. PubMed ID: 21705069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023).
    Gastaldi G; Lucchini B; Thalmann S; Alder S; Laimer M; Brändle M; Wiesli P; Lehmann R;
    Swiss Med Wkly; 2023 Apr; 153():40060. PubMed ID: 37011604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and Attitudes of Primary Healthcare Physicians to Insulin Initiation and Intensification in Saudi Arabia.
    Alhagawy AJ; Yafei S; Hummadi A; Abutaleb R; Hakamy M; Alzughbi T; Gharawi N; Moafa M; Mokali A; Alhiqwy I; Altherwi M
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study.
    Oraii A; Shafiee A; Jalali A; Alaeddini F; Saadat S; Masoudkabir F; Vasheghani-Farahani A; Heidari A; Sadeghian S; Boroumand M; Karimi A; H Franco O
    BMC Endocr Disord; 2022 Oct; 22(1):248. PubMed ID: 36253738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study.
    Lu W; Pikhart H; Tamosiunas A; Kubinova R; Capkova N; Malyutina S; Pająk A; Bobak M
    BMC Public Health; 2022 May; 22(1):883. PubMed ID: 35508994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGLT2 inhibitors: the statins of the 21st century.
    Braunwald E
    Eur Heart J; 2022 Mar; 43(11):1029-1030. PubMed ID: 34741610
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.
    Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Cifkova R; Davletov K; Dilic M; Dolzhenko M; Gaita D; Gotcheva N; Hasan-Ali H; Jankowski P; Lionis C; Mancas S; Milićić D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Ž; Vulić D; Wood D;
    Eur J Prev Cardiol; 2021 May; 28(4):370-379. PubMed ID: 33966079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and Treatment of Dyslipidemia in Diabetes.
    Bahiru E; Hsiao R; Phillipson D; Watson KE
    Curr Cardiol Rep; 2021 Mar; 23(4):26. PubMed ID: 33655372
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.